Gilgamesh Pharma Inc. funding
Gilgamesh Pharma Inc., a pharmaceuticals company based in New York, NY (founded 2025), filed a Form D with the SEC on March 31, 2026 and reported $2.3M raised of a $15M offering. It filed 4 new offerings in this period, totaling $68.3M.
Amount raised$2.3M
Offering size$15M
Filed with the SECMarch 31, 2026
First saleMarch 27, 2026
IndustryPharmaceuticals
SecuritiesOptions or warrants, Other
LocationNew York, NY
Founded2025
Entity typeCorporation
Investors so far3
Minimum investment$50K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 31
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| March 31, 2026 | $2.3M | $15M | Options or warrants, Other |
| March 24, 2026 | $60M | $60M | Equity, Other |
| February 4, 2026 | $6.1M | $6.1M | Equity |
| February 4, 2026 | $0 | $4.4M | Options or warrants, Other |
Other health care rounds in New York
Precision Neuroscience Corp$250M · Sep 28Other Health CareClick Therapeutics, Inc.$50M · Oct 1Other Health CareAmani Therapeutics, Inc.$35M · Oct 1Other Health CareAtmos Clinic, Inc.$6M · Oct 8Other Health CareCAD Therapeutics, Inc.$4M · Oct 2BiotechnologyPreciseDx, Inc.$3.7M · Oct 7Other Health CareHypercell Technologies Inc.$3M · Oct 14BiotechnologyAmorSui Inc.$2.7M · Sep 23Other Health Care